Scholarlink

Purpose <p>Symptoms and baseline laboratory results often fail to identify the underlying cause of polyuria–polydipsia syndrome (PPS). A copeptin-based approach has recently been proposed for the differential diagnosis in adults. Given the rarity and complexity of PPS, national endocrinology societies should provide guidance to minimize diagnostic delays and ensure patients receive the most accurate evaluation.</p> Methods <p>The Hydro-Saline Club conducted a 22-question web-based survey targeting all endocrinologists registered with the Italian Society of Endocrinology in 2024. Data were collected from July 18 to September 22, 2024.</p> Results <p>A total of 120 endocrinologists from 75% of Italian regions completed the survey. 60% worked in university hospitals, while the remainder worked in peripheral hospitals and outpatient clinics. Copeptin testing was available in 58.3% of facilities. However, a basal copeptin evaluation was infrequently requested in PPS, mainly due to assay availability (<i>p</i> &lt; 0.001) and low confidence in results interpretation, which correlated with clinical experience (<i>p</i> = 0.007). The WDT remained the most used stimulation test, with preference driven by personal experience (<i>p</i> = 0.020) rather than facility type. Familiarity with each diagnostic test increased with use, and test choice was apparently not influenced by concerns over potential side effects or accuracy. Rather, the main barrier identified was the perceived caregiving burden associated with the diagnostic process, leading many clinicians to prefer a stepwise diagnostic approach.</p> Conclusion <p>Endocrinological societies should promote awareness of novel, accurate diagnostic tools for PPS and support streamlined referral pathways to centers offering reliable, appropriate testing.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Challenges and unmet needs in diagnosing polyuria-polydipsia syndrome: National survey by the Italian Society of Endocrinology

  • 期刊论文

  • 发表日期：

    2025年11月10日

查看全文
  • Alessandro Maria Berton,
  • Emanuele Ferrante,
  • Paola Razzore,
  • Alessandro Peri,
  • Andrea Benso,
  • Andrea Isidori,
  • Andrea Gerardo Lania,
  • Anna Lisa Bilotta,
  • Carla Scaroni,
  • Carla Paola Costa,
  • Carolina Di Somma,
  • Caterina Magnelli,
  • Chiara Bona,
  • Chiara Diazzi,
  • Chiara Simeoli,
  • Cristina Figuriti,
  • Daniele Marinsalda,
  • Edoardo Santamato,
  • Elisa Giannetta,
  • Emanuela Candida Massimetti,
  • Emanuele Varaldo,
  • Emilia Sbardella,
  • Erminio Massimo Crescenzo,
  • Ernesto Demenis,
  • Fabio Bioletto,
  • Filippo Ceccato,
  • Giorgio Arnaldi,
  • Giovanna Mantovani,
  • Giovanni Corona,
  • Giovanni Battista Ghidella,
  • Giuseppe Antonio Sgrò,
  • Grazia Maria Centaro,
  • Ignazio Bacchi,
  • Jacopo Bertini,
  • Laura Armeli Grigio,
  • Marco Zavattaro,
  • Maria Rosaria Ambrosio,
  • Massimiliano Caprio,
  • Matteo Gasparroni,
  • Mattia Barbot,
  • Maura Arosio,
  • Michela Sibilla,
  • Michele Perrone,
  • Mirko Parasiliti-Caprino,
  • Nunzia Prencipe,
  • Rita Indirli,
  • Romina Di Agostino,
  • Rosario Pivonello,
  • Salvatore Cannavò,
  • Salvatore Volpe,
  • Serena Scalise,
  • Sofia Elena Sorbo,
  • Valentina Gasco,
  • Vincenzo Rochira,
  • Vittorio Oteri,
  • Vittorio Di Pietro

摘要

Purpose

Symptoms and baseline laboratory results often fail to identify the underlying cause of polyuria–polydipsia syndrome (PPS). A copeptin-based approach has recently been proposed for the differential diagnosis in adults. Given the rarity and complexity of PPS, national endocrinology societies should provide guidance to minimize diagnostic delays and ensure patients receive the most accurate evaluation.

Methods

The Hydro-Saline Club conducted a 22-question web-based survey targeting all endocrinologists registered with the Italian Society of Endocrinology in 2024. Data were collected from July 18 to September 22, 2024.

Results

A total of 120 endocrinologists from 75% of Italian regions completed the survey. 60% worked in university hospitals, while the remainder worked in peripheral hospitals and outpatient clinics. Copeptin testing was available in 58.3% of facilities. However, a basal copeptin evaluation was infrequently requested in PPS, mainly due to assay availability (p < 0.001) and low confidence in results interpretation, which correlated with clinical experience (p = 0.007). The WDT remained the most used stimulation test, with preference driven by personal experience (p = 0.020) rather than facility type. Familiarity with each diagnostic test increased with use, and test choice was apparently not influenced by concerns over potential side effects or accuracy. Rather, the main barrier identified was the perceived caregiving burden associated with the diagnostic process, leading many clinicians to prefer a stepwise diagnostic approach.

Conclusion

Endocrinological societies should promote awareness of novel, accurate diagnostic tools for PPS and support streamlined referral pathways to centers offering reliable, appropriate testing.